{"id":37255,"date":"2026-01-27T17:54:46","date_gmt":"2026-01-27T16:54:46","guid":{"rendered":"https:\/\/mabdesign.fr\/?p=37255"},"modified":"2026-01-27T17:54:47","modified_gmt":"2026-01-27T16:54:47","slug":"biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/","title":{"rendered":"bioM\u00e9rieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<p><strong>Marcy-l\u2019\u00c9toile (France), January 22nd, 2026 \u2013 bioM\u00e9rieux, a world leader in the field of&nbsp;<em>in vitro<\/em>&nbsp;diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioM\u00e9rieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide.<\/strong><\/p>\n\n\n\n<p>Cell and gene therapies are innovative medical treatments that use living cells or genetic modification to repair, replace, or restore function in diseased tissues, offering the potential to cure conditions once considered untreatable. From development to manufacturing, ensuring consistency, safety, and reliability is critical to building trust and unlocking the full promise of these groundbreaking treatments.<\/p>\n\n\n\n<p><br><a href=\"https:\/\/www.accellix.com\/news\/biomerieux-acquires-accellix\/\">To know more<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>bioM\u00e9rieux, a world leader in the field of\u00a0in vitro\u00a0diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioM\u00e9rieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide.<\/p>\n","protected":false},"author":6,"featured_media":37256,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,32,18],"tags":[],"class_list":["post-37255","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-our-members","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>bioM\u00e9rieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies - MabDesign<\/title>\n<meta name=\"description\" content=\"bioM\u00e9rieux, a world leader in the field of\u00a0in vitro\u00a0diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioM\u00e9rieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"bioM\u00e9rieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies - MabDesign\" \/>\n<meta property=\"og:description\" content=\"bioM\u00e9rieux, a world leader in the field of\u00a0in vitro\u00a0diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioM\u00e9rieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-27T16:54:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-27T16:54:47+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/01\/BioMerieux_framed_500x282px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2083\" \/>\n\t<meta property=\"og:image:height\" content=\"1175\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Maissa Pote\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maissa Pote\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/\"},\"author\":{\"name\":\"Maissa Pote\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029\"},\"headline\":\"bioM\u00e9rieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies\",\"datePublished\":\"2026-01-27T16:54:46+00:00\",\"dateModified\":\"2026-01-27T16:54:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/\"},\"wordCount\":143,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/01\/BioMerieux_framed_500x282px.jpg\",\"articleSection\":[\"News\",\"Our members\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/\",\"name\":\"bioM\u00e9rieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/01\/BioMerieux_framed_500x282px.jpg\",\"datePublished\":\"2026-01-27T16:54:46+00:00\",\"dateModified\":\"2026-01-27T16:54:47+00:00\",\"description\":\"bioM\u00e9rieux, a world leader in the field of\u00a0in vitro\u00a0diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioM\u00e9rieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/01\/BioMerieux_framed_500x282px.jpg\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/01\/BioMerieux_framed_500x282px.jpg\",\"width\":2083,\"height\":1175},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"bioM\u00e9rieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029\",\"name\":\"Maissa Pote\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g\",\"caption\":\"Maissa Pote\"},\"url\":\"https:\/\/mabdesign.fr\/en\/author\/communication\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"bioM\u00e9rieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies - MabDesign","description":"bioM\u00e9rieux, a world leader in the field of\u00a0in vitro\u00a0diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioM\u00e9rieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/","og_locale":"en_US","og_type":"article","og_title":"bioM\u00e9rieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies - MabDesign","og_description":"bioM\u00e9rieux, a world leader in the field of\u00a0in vitro\u00a0diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioM\u00e9rieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide.","og_url":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/","og_site_name":"MabDesign","article_published_time":"2026-01-27T16:54:46+00:00","article_modified_time":"2026-01-27T16:54:47+00:00","og_image":[{"width":2083,"height":1175,"url":"http:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/01\/BioMerieux_framed_500x282px.jpg","type":"image\/jpeg"}],"author":"Maissa Pote","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"Maissa Pote","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/"},"author":{"name":"Maissa Pote","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029"},"headline":"bioM\u00e9rieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies","datePublished":"2026-01-27T16:54:46+00:00","dateModified":"2026-01-27T16:54:47+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/"},"wordCount":143,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/01\/BioMerieux_framed_500x282px.jpg","articleSection":["News","Our members"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/","url":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/","name":"bioM\u00e9rieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/01\/BioMerieux_framed_500x282px.jpg","datePublished":"2026-01-27T16:54:46+00:00","dateModified":"2026-01-27T16:54:47+00:00","description":"bioM\u00e9rieux, a world leader in the field of\u00a0in vitro\u00a0diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioM\u00e9rieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/01\/BioMerieux_framed_500x282px.jpg","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/01\/BioMerieux_framed_500x282px.jpg","width":2083,"height":1175},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/biomerieux-acquires-accellix-to-elevate-pharmaceutical-quality-control-and-accelerate-advanced-therapiestaconic-biosciences-has-acquired-transcure-bioservices-sas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"bioM\u00e9rieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029","name":"Maissa Pote","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g","caption":"Maissa Pote"},"url":"https:\/\/mabdesign.fr\/en\/author\/communication\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/37255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=37255"}],"version-history":[{"count":2,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/37255\/revisions"}],"predecessor-version":[{"id":37262,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/37255\/revisions\/37262"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/37256"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=37255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=37255"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=37255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}